Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Moderna-UK

NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK

More than 3,700 cases of mpox have been identified in the UK since May 2022

March 15, 2024 Moderna, Moderna-UK, mPower, mpox, mpox vaccine, mRNA-1769, National Institute for Health and Care Research, News, NIHR Clinical Research Network

First UK patients receive experimental mRNA therapy for cancer in global trial

The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359

February 13, 2024 Imperial College Healthcare NHS Trust, Imperial College London, lung cancer, melanoma, Moderna, Moderna-UK, mRNA, mRNA-4359, News, solid tumour cancer
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy